Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TSX/GUD stock hub

TSX/GUD has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TSX/GUDis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

853.8M

Toronto Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TSX/GUD

In the news

Latest news · TSX/GUD

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E45.3

P25 11P50 15.6P75 25.4

Trailing P/E153.8

P25 7.4P50 15.6P75 34.3

ROE0.7

P25 -121.5P50 -40.9P75 0.5

ROIC1.4

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TSX/GUD market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

219

Groups with data

Currency

CAD

Showing 219 of 219 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Employees	830
Employees Change	85%
Employees Change Percent	11.41
Enterprise value	CAD 780.4M
Exchange	Toronto Stock Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA4990531069
Last refreshed	2026-05-10
Market cap	CAD 853.8M
Price	CAD 8.69
Price currency	CAD
Rev Per Employee	615,001.2x
Sector	Healthcare
Sic	2834
Symbol	tsx/GUD
Website	https://www.knighttx.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.66%
EV Earnings	139.11x
EV/EBIT	56.69x
EV/EBITDA	10.55x
EV/FCF	7.72x
EV/Sales	1.53x
FCF yield	11.84%
Forward P/E	45.33x
P/B ratio	1.08x
P/E ratio	153.77x
P/S ratio	1.67x
PE Ratio10 Y	115.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.7%
EBITDA Margin	13.74%
FCF margin	19.81%
Gross margin	45.93%
Gross Profit	CAD 234.5M
Gross Profit Growth	39.92%
Gross Profit Growth Q	98.21%
Gross Profit Growth3 Y	17.01%
Gross Profit Growth5 Y	23.26%
Net Income	CAD 5.6M
Net Income Growth	-49.29%
Net Income Growth Q	502.7%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth5 Y	-34.72%
Pretax Margin	1.54%
Profit Margin	1.1%
Profit Per Employee	CAD 6,759
ROA	0.82
Roa5y	-0.22
ROCE	1.54
ROE	0.71
Roe5y	-0.81
ROIC	1.36
Roic5y	-0.54

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.63%
Cagr1y	43.2%
Cagr3y	22.47%
Cagr5y	10.31%
EPS Growth	-43.43
EPS Growth Q	550
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth5 Y	-31.08
FCF Growth	1,317.24%
FCF Growth Q	1,033.39%
FCF Growth3 Y	44.55%
FCF Growth5 Y	36.97%
OCF Growth	1,068.61%
OCF Growth Q	1,008.83%
OCF Growth10 Y	21.53%
OCF Growth3 Y	42.75%
OCF Growth5 Y	32.28%
Revenue Growth	36.93x
Revenue Growth Q	68.54x
Revenue Growth Quarters	9x
Revenue Growth Years	11x
Revenue Growth3 Y	17.79x
Revenue Growth5 Y	20.64x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.49
Assets	CAD 1.1B
Cash	CAD 143.2M
Current Assets	CAD 447M
Current Liabilities	CAD 192.4M
Debt	CAD 69.8M
Debt EBITDA	CAD 0.94
Debt Equity	CAD 0.09
Debt FCF	CAD 0.69
Equity	CAD 787.3M
Interest Coverage	1.22
Liabilities	CAD 299.3M
Long Term Assets	CAD 639.6M
Long Term Liabilities	CAD 106.9M
Net Cash	CAD 73.4M
Net Cash By Market Cap	CAD 8.6
Net Cash Growth	-30.8%
Net Debt EBITDA	CAD -1.05
Net Debt Equity	CAD -0.09
Net Debt FCF	CAD -0.73
Tangible Book Value	CAD 337.9M
Tangible Book Value Per Share	CAD 3.43
WACC	5.02

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.32
Inventory Turnover	1.96
Net Working Capital	CAD 132.9M
Quick ratio	1.56
Working Capital	CAD 254.5M
Working Capital Turnover	CAD 1.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	1.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	6.5%
1Y total return	43.16%
200-day SMA	6.34
3Y total return	83.72%
50-day SMA	7.1
50-day SMA vs 200-day SMA	50over200
5Y total return	63.35%
All Time High	11.03
All Time High Change	-21.21%
All Time High Date	2016-12-05
All Time Low	3.51
All Time Low Change	147.58%
All Time Low Date	2014-03-03
ATR	0.22
Beta	0.04
Beta1y	0.35
Beta2y	0.42
Ch YTD	43.64
High	8.69
High52	8.7
High52 Date	2026-05-08
High52ch	0%
Low	8.38
Low52	5.5
Low52 Date	2025-05-08
Low52ch	58%
Ma50ch	22.41%
Price vs 200-day SMA	37.17%
RSI	82.48
RSI Monthly	76.44
RSI Weekly	83.26
Sharpe ratio	1.44x
Sortino ratio	2.96
Total Return	1.87%
Tr YTD	43.64
Tr1m	13.6%
Tr1w	15.1%
Tr3m	47.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 13.8M
Operating margin	2.7

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	60,268,856%
Net Borrowing	6,990,000
Shares Insiders	23.46%
Shares Institutions	24.93%
Shares Out	98,251,670
Shares Qo Q	1.44%
Shares Yo Y	-1.87%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 92.6M
Average Volume	69,694.8x
Bv Per Share	8
CAPEX	CAD -4.9M
Ch10y	6.5
Ch1m	13.6
Ch1w	15.1
Ch1y	43.16
Ch3m	47.79
Ch3y	83.72
Ch5y	63.35
Ch6m	43.64
Change	4.07%
Change From Open	3.7
Close	8.35
Days Gap	0.36
Depreciation Amortization	56,358,000
Dollar Volume	1,520,663.1
Earnings Date	2026-05-07
EBIT	CAD 13.8M
EBITDA	CAD 70.1M
EPS	CAD 0.06
F Score	6
FCF	CAD 101.1M
FCF EV Yield	12.96x
FCF Per Share	CAD 1.03
Financing CF	-11,204,000
Fiscal Year End	December
Founded	2,013
Goodwill	95,309,000
Graham Number	3.1886
Graham Upside	-63.31
Income Tax	CAD 2.3M
Investing CF	-96,802,000
Is Primary Listing	1
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Lynch Fair Value	CAD 0.28
Lynch Upside	-96.75
Ma150	6.36
Ma150ch	36.7%
Ma20	7.64
Ma20ch	13.8%
Net CF	-4,107,000
Next Earnings Date	2026-05-14
Open	8.38
P FCF Ratio	8.44
P OCF Ratio	8.06
Position In Range	100
Ppne	30,371,000
Price Date	2026-05-08
Price EBITDA	CAD 12.18
Ptbv Ratio	2.53
Relative Volume	2.53x
Revenue	510,451,000x
SBC By Revenue	1.66x
Share Based Comp	8,483,000
Tax By Revenue	0.44x
Tax Rate	28.8%
Tr6m	43.64%
Volume	174,990

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TSX/GUD pay a dividend?

Capital-return profile for this ticker.

Performance

TSX/GUD stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TSX/GUD?

Insider, institutional, and short-interest positioning.

Institutional ownership

+24.9%

Share of float held by funds and institutions

Insider ownership

+23.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-1.9%

Negative means the company is buying back shares.

Technical

TSX/GUD momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

82.5

Above 70: short-term overbought

Price vs 200-day MA

+37.2%

50/200-day relationship not available

Beta (5Y)

0.04

Less volatile than the market

Sharpe ratio

1.44

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TSX/GUD

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tsx/GUD stock rating?

tsx/GUD is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tsx/GUD analysis?

The full report lives at /stocks/tsx/GUD/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tsx/GUD?

The latest report frames tsx/GUD around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tsx/GUD page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.